Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
Redditors are using John Oliver to give away their coins
Netflix Tests Expanding Games From Mobile to TVs and PCs
7 Best Games to Buy During Steam Summer Sale
Save $20 on the latest Amazon Fire TV Stick model and stream on
Dating method shows TikTok users with a roster of different people
The best pet cameras for keeping tabs on your cat or dog
Get a restored Apple Watch Series 8 for under $250 at Walmart right now
Fortnite July 2023 Leaks: Everything We Know